CCT
ALXN

Country Club Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Country Club Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,782
Closed -$328K – 275
2021
Q2 		$328K Buy
1,782
+10
+0.6% +$1.72K 0.03% 219
2021
Q1 		$272K Buy
1,772
+84
+5% +$13K 0.03% 222
2020
Q4 		$264K Buy
+1,688
New +$217K 0.03% 217

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Country Club Trust's ALXN Position: Q3 2021 in Review

Country Club Trust sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,782 shares — an estimated $328K sold.

Country Club Trust first reported a position in ALXN in Q4 2020 and held it in 3 quarters. The position peaked at $328K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Country Club Trust reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Country Club Trust sold 1,782 Alexion Pharmaceuticals shares in Q3 2021, an estimated $328K.
  • Country Club Trust first reported a position in Alexion Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Country Club Trust's Alexion Pharmaceuticals position peaked at $328K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Country Club Trust's 13F filing for Q3 2021, filed 13 Oct 2021.